French-language VISs
Out-of-date
The translations for some VISs on our website are from previously
published English-language versions that have since been updated.
Unfortunately, IAC is not always able to obtain translations as
updates are issued. Please ensure that your patients receive
information consistent with the current English-language version of
the following VISs.
You are
encouraged to distribute the up-to-date English-language
VIS at the
same time as the translation.
These translations do not
contain the following CDC updates:
- Information was added about MMRV vaccine, tied to the
March 14 MMWR, regarding increased risk of certain adverse events,
including febrile seizures, with MMRV when compared with MMR and
varicella vaccines given separately. Aside from two boxes containing
information about MMRV, both VISs are identical to the previous
editions.
- The new VISs should be used when MMRV is given; but the existing
stocks of the individual MMR and varicella VISs may be used when the
vaccines are given separately.
This translation does not contain the
following CDC updates:
- Section 1: The
answer has been rewritten by CDC.
- Section 2: There
are now 2 doses; the first dose is 12-15 months and the second
dose is 4-6 years.
- CDC added information
on MMRV.
- The URL for Vaccine
Adverse Event Reporting System (VAERS) has changed.
- The URL for the
National Vaccine Injury Compensation Programs has changed.
This translation does not contain the
following CDC updates:- Most of the changes
to this VIS relate to the current exclusive use of the acellular
DTaP; the previous VIS included the whole-cell DTP, which is
no longer used in the U.S.
- Rates of reactions
(problems) that might be expected following DtaP have been
changed and are generally lower that those following DTP.
- The new URL for
the National Injury Compensation Program is listed.
This translation does not contain the
following CDC updates:
- CDC changed the
indication to 1 year or older and has recommended routine use
for children.
- Section 2: Added
persons who work with primates or in research labs to indications
(routine vaccination).
- Added bullet for "persons
who live in communities that have prolonged outbreaks of hepatitis
A."
- Divided the section
into "Who" and "When" parts.
- Removed southern
Europe from list of regions with high rates of hepatitis A.
- Section 3: Added
bullet about allergy to vaccine component.
- Changed wording,
particularly the statement on pregnancy, and made list into
bullets.
- Minor changes to
part 4, 5, and 6 to be consistent with other recent VISs.
- Removed the section
on immune globulin.
This translation does not contain the
following CDC updates:
- The number of new
infections occurring annually is listed as 80,000 (previously
200,000).
- "Sharing of
needles" when injecting illegal drugs has been added as
a way of spreading the virus.
- The targeted groups
to be vaccinated has been expanded to include public safety
workers who might be exposed to infected blood or body fluids,
household contacts of persons with chronic HBV infection, and
hemodialysis patients.
- A time frame "in
6 months" has been added to the risk factor "people
who have more than one sex partner."
- Information about
the two-dose adolescent vaccine series has been added.
- The statement "Serious
allergic reactions are extremely rare with any vaccine" has
been added.
- The website of
Vaccine Adverse Event Reporting System has been added.
- A new URL for the
National Vaccine Injury Compensation Program is listed.
This translation does not contain the
following CDC updates:
- CDC added recommending
vaccination of children aged 24-59 months and their contacts.
- Section
3: CDC added to the list of people at high risk for complications
from influenza, "People with certain muscle or nerve disorders
(such as seizure disorders or severe cerebral palsy) that can
lead to breathing or swallowing disorders."
This translation does not contain the
following CDC updates:
- Female patients
are now advised to postpone pregnancy for 4 weeks after receiving
MMR vaccine (version 12/16/98 read "3 months").
- The website of
the Vaccine Adverse Event Reporting System has
been added.
- A new URL for the
National Vaccine Injury Compensation Program
has been added.
Thanks to
the Minnesota Department of Health and the American Embassy Tunis
- Medical Unit for their translations.This page was updated on
March 13, 2008 |